Keloid Treatment

Keloid Treatment addresses one of the most challenging fibrotic responses in dermatology, where excessive collagen deposition extends beyond the original wound boundary and leads to persistent, raised, and often symptomatic scars. Unlike hypertrophic scars that may regress over time, keloids demonstrate uncontrolled fibroblast proliferation and abnormal extracellular matrix accumulation. This complex pathology makes the topic a significant clinical focus at every global Dermatology Conference, where innovative management strategies continue to evolve. Closely associated with pathologic scar management, keloid treatment requires a balance between surgical precision, anti-fibrotic therapy, and long-term recurrence prevention.

Rather than viewing keloids as purely cosmetic concerns, this session approaches them as biologically active scars driven by dysregulated wound healing pathways. Participants will examine the role of transforming growth factor-beta signaling, genetic predisposition, and mechanical tension in stimulating excessive collagen synthesis. Certain anatomical regions, including the chest, shoulders, jawline, and earlobes, demonstrate higher susceptibility due to tension dynamics and fibroblast sensitivity.

The session explores multimodal therapeutic approaches rather than single-modality correction. Intralesional corticosteroids remain foundational, while combination therapies incorporating 5-fluorouracil, cryotherapy, laser-assisted remodeling, and silicone-based occlusion demonstrate improved outcomes. Surgical excision is carefully evaluated within the context of recurrence risk, emphasizing adjunctive postoperative protocols to prevent regrowth.

Emerging treatments such as botulinum toxin injections, pressure therapy, and targeted anti-fibrotic agents are reviewed for their role in modulating collagen overproduction. Early intervention in high-risk wounds is emphasized as a preventive strategy. Attention is also given to patient counseling, as recurrence rates and prolonged treatment courses require realistic expectation setting.

Ethnic predisposition and darker skin phototypes are discussed in relation to higher incidence rates, reinforcing the need for individualized treatment planning. Psychological impact, particularly for visible lesions, highlights the importance of compassionate management alongside technical expertise.

By integrating molecular understanding with clinical strategy, this session equips dermatologists with comprehensive tools to manage keloids effectively while minimizing recurrence and optimizing scar aesthetics.